HER2 Testing in Other Solid Tumors and Implications for Treatment

Course overview

This microlearning activity is designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of emerging research in pan-tumor HER2 testing in patients with advanced solid tumors and of treatment options based on HER2 results. This activity will also address designing laboratory workflows to achieve efficient, accurate, and equitable pan-tumor HER2 testing. The microlearning design of this activity allows for a brief and focused exploration of this topic.